118(P-52) ロゼオフィリンの全合成研究(ポスター発表の部)
スポンサーリンク
概要
- 論文の詳細を見る
Roseophilin (1) isolated from Streptomyces griseoviridis by Seto et al. in 1992, exhibits potent cytotoxicity against human cancer cell lines. The structure of 1 was revealed by extensive spectroscopic studies to have a unique ansa-bridged cyclopenta[b]pyrrole skeleton incorporated with a characteristic conjugated heterocyclic ring system containing furan and pyrrole moieties. Its remarkable biological properties as well as its novel structural features make 1 an exceptionally intriguing and timely target for total synthesis. In 1998, Furstner et al. reported the first total synthesis of 1. Subsequently to this report, the formal total synthesis of 1 was disclosed by several research groups. Herein we wish to present our own results with respect to the formal total synthesis of 1. Roseophilin (1) can be disconnected retrosynthetically to provide the heterobiaryl part 2 and the macrotricyclic part 3. At first, we pursued the synthesis of 2 starting from the known 3-chloro-2-formylpyrrole (5) prepared from commercially available 4-nitropyridine N-oxide (12). Conversion of 5 to the diketone 15 was conducted by a five-step sequence of reactions. The diketone 15 was treated with a catalytic amount of camphorsulfonic acid in methanol to give the desired 2-furylpyrrole 17 (76%) in one-pot reaction by sequential deprotection of the THP group, ring closure, and O-methylation. Further deprotection of the tosyl group in 17 furnished the heterobiaryl part 2. Next, we investigated the synthesis of the macrotricyclic part 3, the coupling partner of 2, staring from the known 3-formylpyrrole (11). Thus, 3-formylpyrrole (11) was transformed to the iodide 23, the substrate for the first key macrocyclization, in 34% over all yield through an eight-step sequence. The crucial macrocyclization was found to be effected by treating 23 with cesium carbonate in DMF at 90℃ under a diluted condition (5.0mM), providing the macrocyclic olefin 24 in 38% yield. After hydrogenation of the double bond in 24, the resulting product 25 was further converted to the bromopyrrole 27, the second key cyclization precursor, in 63% overall yield via three step operations. Lithiation of 27 with n-BuLi at ?78℃ underwent the cyclization, affording the desired pyrrole-fused cyclopentanone system 28 in 39% yield. Finally, 28 was subjected to demethoxycarbonylation to give the requisite macrotricyclic part 3. The total synthesis of roseophilin (1) by the coupling reaction of 2 and 3 has been established by Furstner et al., therefore, our synthesis of 2 and 3 constitutes the formal total synthesis of 1. In summary, we have succeeded in developing a novel synthetic pathway to the heterobiaryl part 2 and the macrotricyclic part 3 of roseophilin (1). The sequence for the synthesis of 2 involves the furan ring formation from the diketone 15 as the key step. Furthermore, the method for the synthesis of 3 features the macrocyclization of the iodide 23 to elaborate the desired thirteen-membered carbocycle 24 (23→24) and the base-induced annulation of the bromopyrrole 27 to construct the requisite pyrrole-fused cyclopentanone ring system 28 (27→28) as the key steps. Our successful synthesis of 2 and 3 signifies the formal total synthesis of 1.
- 天然有機化合物討論会の論文
- 2000-10-01
著者
関連論文
- P-58 5-ビニルチオラクトマイシン類の両対掌体の合成とその生物活性(ポスター発表の部)
- P-20 2-アミノイミダゾール-4-アルデヒド誘導体の新合成法の開発とそのアルカロイド合成への応用(ポスター発表の部)
- 10 制癌活性物質カルチノフィリンの合成研究(口頭発表の部)
- 8 光学活性FR900482の合成研究(口頭発表の部)
- 52 光学活性キノカルシンの合成研究(口頭発表の部)
- 38 ネオカルチノスタチンクロモフォア関連化合物の合成研究(口頭発表の部)
- 58(P1-6) 14-フロロアントラサイクリン類の合成とその制癌活性(ポスター発表の部)
- 14-Fluoroanthracyclines. : Novel Syntheses and Antitumor Activity
- 18 ノガラマイシン類の全合成(口頭発表の部)
- 66 天然型(+)-セスバニミドAおよび(-)-セスバニミドBの全合成
- Novel Synthesis of Three Types of C-Terminal Components of Renin Inhibitors from Unnatural(2S, 3S)-Tartaric Acid
- 67 光学活性カルバペネム鍵合成中間体の合成研究(口頭発表の部)
- 65 生合成仮説を考慮した除草活性物質(+)-ヒダントサイジンの合成(ポスター発表の部)
- P-1 抗生物質(R)-(+)-チオラクトマイシンの全合成(ポスター発表の部)
- 12 ヒンバシン類縁体の合成とそのムスカリンM_2サブタイプ受容体拮抗作用(口頭発表の部)
- 118(P-52) ロゼオフィリンの全合成研究(ポスター発表の部)
- 効率的合成法の開発に感動と興奮を求めて
- 49(P07) ムスカリンM_2サブタイプレセプターアンタゴニスト(+)-ヒンバシンの全合成(ポスター発表の部)
- 生物活性物質の効率的合成法の開発とその創薬化学への展開
- 30 トポイソメラーゼ-II阻害活性を有する海綿由来ポポロフアノンEの全合成研究(口頭発表の部)
- 92(P08) 光学活性(-)-フペルジンAおよびその含フッ素類縁体の合成研究(ポスター発表の部)
- P-34 光学活性デュオカルマイシンAおよびその類縁体の合成と抗腫瘍活性(ポスター発表の部)
- キノカルシンの全合成
- エンイン構造を有する制癌活性天然物の合成研究
- A Highly Stereoselective Synthesis of (3S, 4S)-Statine and (3S, 4S)-Cyclohexylstatine
- 生物活性物質の合成研究--最近の進歩
- 91 デュオカルマイシン類の合成研究(口頭発表の部)
- Synthesis of Novel 13-Methyl-13-dihydroanthracyclines
- Synthesis of 4-Demethoxyanthracyclines Carrying a Lipophilic Alkanoyl Group at the C_9-Position
- 40 光学活性4-デメトキシアドリアマイシン及び4-デメトキシダウノルビシンの全合成研究
- 115(P52) 抗真菌活性天然物UK-2Aおよびその類縁体の合成と生理活性(ポスター発表の部)
- 9 中性スフィンゴミエリナーゼ阻害剤(+)-スキホスタチンの全合成(口頭発表の部)
- オレフィンメタセシスを用いる8員環の構築
- Asymmetric Reduction of 4-Phenyl-3 (E)-buten-2-one by Using Lithium Aluminum Hydride Partially Decomposed with (-)-N-Methylephedrine and Achiral Secondary Amine
- Lithium Aluminum Hydride Partially Decomposed with (-)-N-Methylephedrine and 2-Alkylaminopyridine : An Improved Chiral Hydride Useful for the Practical Asymmetric Reduction of Achiral Cyclic Ketones
- キノカルシンの全合成
- エンイン構造を有する制癌活性天然物の合成研究
- Synthesis of Novel Monobactams Bearing an (R)-1-Hydroxyethyl Group and an (S)-1-Carbamoyl-oxyethyl Group at the C_-Positions
- 光学活性な生物活性化合物の合成研究
- ノガラマイシン類の全合成
- 1β-メチルカルバペネム鍵合成中間体の合成
- セスバニミド類の合成